Programmable PROTAC delivery for precise and spatiotemporal protein degradation.

Area of Science:

• Biotechnology
• Nanomedicine
• Chemical Biology

Background:

• Targeted protein degradation (TPD) using proteolysis-targeting chimeras (PROTACs) offers a novel therapeutic strategy for previously undruggable targets.
• Current PROTAC limitations include poor cell permeability and suboptimal in vivo biodistribution, hindering therapeutic efficacy.
• There is a critical need for programmable PROTAC delivery systems that provide spatial and temporal control over TPD.

Purpose of the Study:

• To review recent advancements in nanoparticle-based PROTAC delivery systems.
• To highlight the role of nanoparticle chemistry and surface engineering in achieving spatiotemporally controlled protein degradation.
• To discuss the integration of stimuli-responsive release, immune modulation, imaging, and co-therapies within nanocarrier designs.

Main Methods:

• Focus on lipid-based, polymeric, and inorganic nanoparticles for PROTAC delivery.
• Exploration of nanoparticle surface engineering for controlled drug release and targeting.
• Discussion of integrating multiple functionalities into nanocarriers for enhanced therapeutic outcomes.

Main Results:

• Nanoparticles can overcome PROTAC delivery challenges, improving cell permeability and biodistribution.
• Stimuli-responsive nanoparticles enable precise spatiotemporal control over TPD.
• Multifunctional nanocarriers can combine PROTAC delivery with immune modulation, imaging, and synergistic therapies.

Conclusions:

• Rational nanocarrier design is crucial for unlocking the therapeutic potential of PROTACs.
• Programmable, multifunctional nanodelivery systems are key to advancing targeted protein degradation therapies.
• Integration of synthetic and self-assembly chemistry will drive the development of next-generation PROTAC delivery systems.